send link to app

EONMED


4.0 ( 5520 ratings )
Gesundheit und Fitness
Entwickler EON Biotechnology Limited
Frei

EONMED Mobile App is India’s one-of-its-kind ICMR approved; Rapid Antigen screening app. It provides a thorough guidance from conducting the test yourself to generating its result. Our Saliva based Self Test kit, Angcard blended with the AI (Artificial Intelligence) based Result Analyzer feature of EONMED App displays accurate result within 15-20 minutes.
Conduct your Rapid Antigen @home with EONMED Mobile App and minimize the chances of getting infected with Omicron and Corona Virus. We have chosen technology as our weapon in the fight against Covid-19. EONMED Mobile App is revolutionizing the Biotech space by collaborating consumer app technology with the precision of clinical practices to deliver universally beneficial healthcare outcomes.

Benefits and Features of EONMED Mobile App: Features:
• Convenience of Testing at Home & Ability to schedule tests from the app.
• Online Doctor Consultation
• Disease Management
• Patient Management
• All Doctor Prescription & Lab Tests in single place with exclusive access to the User.
• Digital Test certificate for Angcard Rapid Antigen Saliva Test.
• Anti-Counterfeit protection of test kit through QR code
• Artificial Intelligence (AI) automatically generates your Health Pass
• Single cloud-based platform that provides 360° view of Patients, Test results, Time logs, Analytics & trends of cases – positive, immune, negative.

EONMED Mobile App authenticates disease detection by performing a medical examination using the mobile device/ product. It analyses the outcome of medical examination using the AI issuing & validating the examination certificate using a distributed ledger platform. Disclaimer: The EONMED App is an advanced diagnostic app which is not expected to replace the primary means of contacting emergency services or critical public welfare services. The app is not a replacement for a normal voice call with the appropriate authorities in an emergency.